YBX1 and breast cancer: For example, under hypoxia, Goodarzi et al. found that tRFAsp-GTC and tRFGly-TCC produced by breast cancer cells competitively bind YBX1 and replace the 3′UTR in YBX1, resulting in reduced stability of endogenous oncogene transcripts, thereby inhibiting tumor cell proliferation 40.